AIDS Treatment News logo      

January 13, 2010

Switching From Kaletra to Isentress: Benefits and Hazards

"Switching from Kaletra (lopinavir plus ritonavir) to Isentress (raltegravir) when viral load is undetectable might help reduce elevated cholesterol and triglyceride (lipid) levels, but it might also raise the risk of losing control of the virus, according to two studies published online January 13 in The Lancet and reported by MedPage Today."

Read more in POZ, January 13, 2010.